Advanced search
Publication Cover
Expert Opinion on Drug Discovery Volume 2, 2007 - Issue 7
Submit an article Journal homepage
55
Views
0
CrossRef citations to date
0
Altmetric
Reviews

Drug discovery using the regulation of gene expression

Yves St-Pierre University of Québec, INRS-Institut Armand-Frappier, 531 Boul. des Prairies, Laval, Québec, H7V 1B7, Canada +1 450 686 5354; +1 450 686 5501; [email protected]
Pages 987-1000 | Published online: 08 Aug 2007

Bibliography

  • CLARK EA, GOLUB TR, LANDER ES, HYNES RO: Genomic analysis of metastasis reveals an essential role for RhoC. Nature (2000) 406(6795):532-535.
  • KANG Y, SIEGEL PM, SHU W, DROBNJAK M et al.: A multigenic program mediating breast cancer metastasis to bone. Cancer Cell (2003) 3(6):537-549.
  • MOISAN S, DEMERS M, MERCIER J, MAGNALDO T, POTWOROWSKI EF, ST-PIERRE Y: Upregulation of galectin-7 in murine lymphoma cells is associated with progression toward an aggressive phenotype. Leukemia (2003) 17(4):751-759.
  • DEMERS M, BIRON-PAIN K, HéBERT J, LAMARRE A, MAGNALDO T, ST-PIERRE Y: Galectin-7 in lymphoma: elevated expression in human lymphoid malignancies and decreased lymphoma dissemination by antisense strategies in experimental model. Cancer Res. 67(6):2824-2829.
  • POTTI A, DRESSMAN HK, BILD A: Genomic signatures to guide the use of chemotherapeutics. Nat. Med. (2006) 12(11):1294-1300.
  • ARMSTRONG SA, STAUNTON JE, SILVERMAN JB et al.: MLL translocations specify a distinct gene expression profile that distinguishes a unique leukemia. Nat. Genet. (2002) 30(1):41-47.
  • VAN DE VIJVER MJ, HE YD, VAN'T VEER LJ et al.: A gene-expression signature as a predictor of survival in breast cancer. N. Engl. J. Med. (2002) 347(25):1999-2009.
  • VAN'T VEER LJ, DAI H, VAN DE VIJVER MJ et al.: Gene expression profiling predicts clinical outcome of breast cancer. Nature (2002) 415(6871):530-536.
  • RAMILO O, ALLMAN W, CHUNG W et al.: Gene expression patterns in blood leukocytes discriminate patients with acute infections. Blood (2006) 109(5):2066-2077.
  • MCMANUS BM, YANAGAWA B, REZAI N et al.: Genetic determinants of coxsackievirus B3 pathogenesis. Ann. NY Acad. Sci. (2002) 975:169-179.
  • PEDERSON T: The immunome. Mol. Immunol. (1999) 36(15-16):1127-1128.
  • DE GROOT AS: Immunomics: discovering new targets for vaccines and therapeutics. Drug Discov. Today (2006) 11(5-6):203-209.
  • SUDA T, TSUNODA T, UCHIDA N et al.: Identification of secernin 1 as a novel immunotherapy target for gastric cancer using the expression profiles of cDNA microarray. Cancer Sci. (2006) 97(5):411-419.
  • CHURCHILL GA: Fundamentals of experimental design for cDNA microarrays. Nat. Genet. (2002) 32:490-495.
  • COOLEY L, KELLEY R, SPRADLING AC: Insertional mutagenesis of the Drosophila genome with single P elements. Science (1988) 239(4844):1121-1128.
  • UREN AG, KOOL J, BERNS A, VAN LOHUIZEN M: Retroviral insertional mutagenesis: past, present and future. Oncogene (2005) 24(52):7656-7672.
  • SUZUKI T, SHEN H, AKAGI K et al.: New genes involved in cancer identified by retroviral tagging. Nat. Genet. (2002) 32(1):166-174.
  • NEKRUTENKO A, LI WH: Transposable elements are found in a large number of human protein-coding genes. Trends Genet. (2001) 17(11):619-621.
  • DUPUY AJ, AKAGI K, LARGAESPADA DA, COPELAND NG, JENKINS NA: Mammalian mutagenesis using a highly mobile somatic Sleeping Beauty transposon system. Nature (2005) 436(7048):221-226.
  • IVICS Z, HACKETT PB, PLASTERK RH, IZSVAK Z: Molecular reconstruction of sleeping beauty, a Tc1-like transposon from fish, and its transposition in human cells. Cell (1997) 91(4):501-510.
  • ELNITSKI L, JIN VX, FARNHAM PJ, JONES SJ: Locating mammalian transcription factor binding sites: a survey of computational and experimental techniques. Genome Res. (2006)16(12):1455-1464.
  • KUSHNER PJ, AGARD DA, GREENE GL et al.: Estrogen receptor pathways to AP-1. J. Steroid Biochem. Mol. Biol. (2000) 74(5):311-317.
  • RAY A, PREFONTAINE KE, RAY P: Down-modulation of interleukin-6 gene expression by 17 β-estradiol in the absence of high affinity DNA binding by the estrogen receptor. J. Biol. Chem. (1994) 269(17):12940-12946.
  • DONG J, TSAI-MORRIS CH, DUFAU ML: A novel estradiol/estrogen receptor α-dependent transcriptional mechanism controls expression of the human prolactin receptor. J. Biol. Chem. (2006) 281(27):18825-18836.
  • SOLOMON MJ, LARSEN PL, VARSHAVSKY A: Mapping protein-DNA interactions in vivo with formaldehyde: evidence that histone H4 is retained on a highly transcribed gene. Cell (1988) 53(6):937-947.
  • WEINMANN AS, FARNHAM PJ: Identification of unknown target genes of human transcription factors using chromatin immunoprecipitation. Methods (2002) 26(1):37-47.
  • BERNSTEIN BE, HUMPHREY EL, LIU CL, SCHREIBER SL: The use of chromatin immunoprecipitation assays in genome-wide analyses of histone modifications. Methods Enzymol. (2004) 376:349-360.
  • CICCONE DN, MORSHEAD KB, OETTINGER MA: Chromatin immunoprecipitation in the analysis of large chromatin domains across murine antigen receptor loci. Methods Enzymol. (2004) 376:334-348.
  • DAS PM, RAMACHANDRAN K, VANWERT J, SINGAL R: Chromatin immunoprecipitation assay. Biotechniques (2004) 37(6):961-969.
  • KIRMIZIS A, BARTLEY SM, FARNHAM PJ: Identification of the polycomb group protein SU(Z)12 as a potential molecular target for human cancer therapy. Mol. Cancer Ther. (2003) 2(1):113-121.
  • CHAYA D, ZARET KS: Sequential chromatin immunoprecipitation from animal tissues. Methods Enzymol. (2004) 376:361-372.
  • REN B, DYNLACH BD: Use of chromatin immunoprecipitation assays in genome-wide location analysis of mammalian transcription factors. Methods Enzymol. (2000) 376:304-315.
  • BUCK MJ, NOBEL A, LIEB J: ChIPOTle: A user-friendly tool for the analysis of ChIP–chip data. Genome Biol. (2005) 6(11):R97.
  • WEI CL, WU Q, VEGA VB et al.: A global map of p53 transcription-factor binding sites in the human genome. Cell. (2006) 124(1):207-219.
  • ZELLER KI, ZHAO X, LEE CW et al.: Global mapping of c-Myc binding sites and target gene networks in human B cells. Proc. Natl. Acad. Sci. USA. (2006) 103(47):17834-17839.
  • LEVY DE, DARNELL JE Jr: Stats: transcriptional control and biological impact. Nat. Rev. Mol. Cell Biol. (2002) 3(9):651-662.
  • FU XY, SCHINDLER C, IMPROTA T, AEBERSOLD R, DARNELL JE Jr: The proteins of ISGF-3: the interferon α-induced transcriptional activator, define a gene family involved in signal transduction. Proc. Natl. Acad. Sci. USA (1992) 89(16):7840-7843.
  • SCHINDLER C, FU XY, IMPROTA T, AEBERSOLD R, DARNELL JE Jr: Proteins of transcription factor ISGF-3: one gene encodes the 91 and 84 kDa ISGF-3 proteins that are activated by inteferon-α. Proc. Natl. Acad. Sci. USA (1992) 89(16):7836-7839.
  • SCHINDLER C, SHUAI K, PREZIOSO VR, DARNELL JE Jr: Interferon-dependent tyrosine phosphorylation of a latent cytoplasmic transcription factor. Science (1992) 257(5071):809-815.
  • AARONSON DS, HORVATH CM: A road map for those who don't know JAK-STAT. Science (2002) 296(5573):1653-1655.
  • HEINRICH PC, BEHRMANN I, MULLER-NEWEN G, SCHAPER F, GRAEVE L: Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway. Biochem. J. (1998) 334(Part 2):297-314.
  • SARTOR CI, DZIUBINSKI ML, YU CL, JOVE R, ETHIER SP: Role of epidermal growth factor receptor and STAT-3 activation in autonomous proliferation of SUM-102PT human breast cancer cells. Cancer Res. (1997) 57(5):978-987.
  • DEO DD, AXELRAD TW, ROBERT EG, MARCHESELLI V, BAZAN NG, HUNT JD: Phosphorylation of STAT-3 in response to basic fibroblast growth factor occurs through a mechanism involving platelet-activating factor, JAK-2, and Src in human umbilical vein endothelial cells. Evidence for a dual kinase mechanism. J. Biol. Chem. (2002) 277(24):21237-21245.
  • BOCCACCIO C, ANDO M, TAMAGNONE L et al.: Induction of epithelial tubules by growth factor HGF depends on the STAT pathway. Nature (1998) 391(6664):285-288.
  • HUNG W, ELLIOTT B: Co-operative effect of c-Src tyrosine kinase and Stat3 in activation of hepatocyte growth factor expression in mammary carcinoma cells. J. Biol. Chem. (2001) 276(15):12395-12403.
  • ZHANG YW, WANG LM, JOVE R, VANDE WOUDE GF: Requirement of Stat3 signaling for HGF/SF-Met mediated tumorigenesis. Oncogene (2002) 21(2):217-226.
  • VIGNAIS ML, SADOWSKI HB, WALTING D, ROGERS NC, GILMAN M: Platelet-derived growth factor induces phosphorylation of multiple JAK family kinases and STAT proteins. Mol. Cell Biol. (1996) 16(4):1759-1769.
  • FUNAMOTO M, FUJIO Y, KUNISADA K et al.: Signal transducer and activator of transcription 3 is required for glycoprotein 130-mediated induction of vascular endothelial growth factor in cardiac myocytes. J. Biol. Chem. (2000) 275(14):10561-10566.
  • YU H, JOVE R: The STATs of cancer – new molecular targets come of age. Nat. Rev. Cancer (2004) 4(2):97-105.
  • ZHNAG J, SHEN B, LI Y, SUN Y: STAT3 exerts two-way regulation in the biological effects of IL-6 in M1 leukemia cells. Leuk. Res. (2001) 25(6):463-472.
  • EPLING-BURNETTE PK, LIU JH, CATLETT-FALCONE R et al.: Inhibition of STAT3 signaling leads to apoptosis of leukemic large granular lymphocytes and decreased Mcl-1 expression. J. Clin. Invest. (2001) 107(3):351-362.
  • MORA LB, BUETTNER R, SEIGNE J et al.: Constitutive activation of Stat3 in human prostate tumors and cell lines: direct inhibition of Stat3 signaling induces apoptosis of prostate cancer cells. Cancer Res. (2002) 62(22):6659-6566.
  • MORTON NM, DE GROOT RP, CAWTHORNE MA, EMILSSON V : Interleukin-1β activates a short STAT-3 isoform in clonal insulin-secreting cells. FEBS Lett. (1999) 442(1):57-60.
  • SCHAEFER TS, SANDERS LK, NATHANS D: Cooperative transcriptional activity of Jun and Stat3 β, a short form of Stat3. Proc. Natl. Acad. Sci. USA (1995) 92(20):9097-9101.
  • CHEN X, DUDGEON N, SHEN L, WANG JH: Chemical modification of gene silencing oligonucleotides for drug discovery and development. Drug Discov. Today (2005) 10(8):587-593.
  • OCHIETTI B, GUERIN N, VINOGRADOV SV et al.: Altered organ accumulation of oligonucleotides using polyethyleneimine grafted with poly(ethylene oxide) or pluronic as carriers. J. Drug Target (2002) 10(2):113-121.
  • OCHIETTI B, LEMIEUX P, KABANOV AV et al.: Inducing neutrophil recruitment in the liver of ICAM-1-deficient mice using polyethyleneimine grafted with Pluronic P123 as an organ-specific carrier for transgenic ICAM-1. Gene Ther. (2002) 9(14):939-945.
  • FIRE A, XU S, MONTGOMERY MK, KOSTAS SA, DRIVER SE, MELLO CC: Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature (1998) 391(6669):806-811.
  • DU K, HERZIG S, KULKARNI RN, MONTMINY M: TRB3: a tribbles homolog that inhibits Akt/PKB activation by insulin in liver. Science (2003) 300(5625):1574-1577.
  • KNOCH KP, BERGERT H, BORGONOVO B et al.: Polypyrimidine tract-binding protein promotes insulin secretory granule biogenesis. Nat. Cell Biol. (2004) 6(3):207-214.
  • KOO SH, SATOH H, HERZIG S et al.: PGC-1 promotes insulin resistance in liver through PPAR-α-dependent induction of TRB-3. Nat. Med. (2004) 10(5):530-534.
  • YAMAUCHI T, KAMON J, ITO Y et al.: Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature (2003) 423(6941):762-769.
  • TOYOFUKU T, ZHANG H, KUMANOGOH A et al.: Guidance of myocardial patterning in cardiac development by Sema6D reverse signalling. Nat. Cell Biol. (2004) 6(12):1204-1211.
  • KUWAHARA K, WANG Y, MCANALLY J et al.: TRPC6 fulfills a calcineurin signaling circuit during pathologic cardiac remodeling. J. Clin. Invest. (2006) 116(12):3114-3126.
  • RAMANA KV, WILLIS MS, WHITE MD et al.: Endotoxin-induced cardiomyopathy and systemic inflammation in mice is prevented by aldose reductase inhibition. Circulation (2006) 114(17):1838-1846.
  • EBERT BL, LEE MM, PRETZ JL et al.: An RNA interference model of RPS19 deficiency in Diamond-Blackfan anemia recapitulates defective hematopoiesis and rescue by dexamethasone: identification of dexamethasone-responsive genes by microarray. Blood (2005) 105(12):4620-4626.
  • HUO XF, ZHANG JW: Annexin 1 regulates the erythroid differentiation through ERK signaling pathway. Biochem. Biophys. Res. Commun. (2005) 331(4):1346-1352.
  • GHAFFARI S, KITIDIS C, ZHAO W et al.: AKT induces erythroid-cell maturation of JAK2-deficient fetal liver progenitor cells and is required for Epo regulation of erythroid-cell differentiation. Blood (2006) 107(5):1888-1891.
  • MILLER VM, GOUVION CM, DAVIDSON BL, PAULSON HL: Targeting Alzheimer's disease genes with RNA interference: an efficient strategy for silencing mutant alleles. Nucleic Acids Res. (2004) 32(2):661-668.
  • SZE CI, SU M, PUGAZHENTI S et al.: Down-regulation of WW domain-containing oxidoreductase induces τ phosphorylation in vitro. A potential role in Alzheimer's disease. J. Biol. Chem. (2004) 279(29):30498-30506.
  • XIE Z, ROMANO DM, TANZI RE : RNA interference-mediated silencing of X11α and X11β attenuates amyloid β-protein levels via differential effects on β-amyloid precursor protein processing. J. Biol. Chem. (2005) 280(15):15413-15421.
  • ELBASHIR SM, LENDECKEL W, TUSCHL T: RNA interference is mediated by 21- and 22-nucleotide RNAs. Genes Dev. (2001) 15(2):188-200.
  • ELBASHIR SM, HARBOTH J, LENDECKEL W, YALCIN A, WEBER K, TUSCHL T: Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature (2001) 411(6836):494-498.
  • LEE RC, FEINBAUM RL, AMBROS V: The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell (1993) 75(5):843-854.
  • REINHART BJ, WEINSTEIN EG, RHOADES MW, BARTEL B, BARTEL DP: MicroRNAs in plants. Genes Dev. (2002) 16(13):1616-1626.
  • BRENNECKE J, HIPFNER DR, STARK A, RUSSELL RB, COHEN SM: Bantam encodes a developmentally regulated microRNA that controls cell proliferation and regulates the proapoptotic gene hid in Drosophila. Cell (2003) 113(1):25-36.
  • CHEN K, RAJEWSKY N: The evolution of gene regulation by transcription factors and microRNAs. Nat. Rev. Genet. (2007) 8(2):93-103.
  • AMBROS V: The functions of animal microRNAs. Nature (2004) 431(7006):350-355.
  • BARTEL BP: MicroRNAs: genomics, biogenesis, mechanism, and function. Cell (2004) 116(2):281-297.
  • SEMPERE LF, FREEMANTLE S, PITHA-ROWE I, MOSS E, DMITROVSKY E, AMBROS V: Expression profiling of mammalian microRNAs uncovers a subset of brain-expressed microRNAs with possible roles in murine and human neuronal differentiation. Genome biol. (2004) 5(3):R13.
  • LEE RC, AMBROS V: An extensive class of small RNAs in Caenorhabditis elegans. Science (2001) 294(5543):862-864.
  • LAGOS-QUINTANA M, RAUHUT R, YALCIN A, MEYER J, LENDECKEL W, TUSCHL T: Identification of tissue-specific microRNAs from mouse. Curr. Biol. (2002) 12(9):735-739.
  • CHEN CZ, LI L, LOLISH HF, BARTEL DP: MicroRNAs modulate hematopoietic lineage differentiation. Science (2004) 303(5654):83-86.
  • HOUBAVIY HB, MURRAY MF, SHARP PA: Embryonic stem cell-specific microRNAs. Dev. Cell (2003) 5(2):351-358.
  • ZHAO Y, SAMAL E, SRIVASTAVA D: Serum response factor regulates a muscle-specific microRNA that targets Hand2 during cardiogenesis. Nature (2005) 436(7048):214-220.
  • POY MN, ELIASSON L, KRUTZFELDT J et al.: A pancreatic islet-specific microRNA regulates insulin secretion. Nature (2004) 432(7014):226-230.
  • JOPLING CL, YI M, LANCASTER AM, LEMON SM, SARNOW P: Modulation of hepatitis C virus RNA abundance by a liver-specific MicroRNA. Science (2005) 309(5740):1577-1581.
  • BIELEN J, LIU N, BURNETT BG, PITTMAN RN, BININI NM: MicroRNA pathways modulate polyglutamine-induced neurodegeneration. Mol. Cell (2006) 24(1):157-163.
  • VAN ROOIJ E, SUTHERLAND LB, LIU N et al.: A signature pattern of stress-responsive microRNAs that can evoke cardiac hypertrophy and heart failure. Proc. Natl. Acad. Sci. USA (2006) 103(48):18255-18260.
  • CALIN CA, CROCE CM: MicroRNA signatures in human cancers. Nat. Rev. Cancer (2006) 6(11):857-66.
  • CIMMINO A, CALIN CA, FABBRI M et al.: miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc. Natl. Acad. Sci. USA (2005) 102(39):13944-13949.
  • CALIN CA, CROCE CM: Genomics of chronic lymphocytic leukemia microRNAs as new players with clinical significance. Semin. Oncol. (2006) 33(2):167-173.
  • MICHAEL MZ, O'CONNOR SM, VAN HOLST PELLEKAAN NG, YOUNG GP, JAMES RJ: Reduced accumulation of specific microRNAs in colorectal neoplasia. Mol. Cancer Res. (2003) 1(12):882-891.
  • CHAN JA, KRICHEVSKY AM, KOSIK KS: MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. Cancer Res. (2005) 65(14):6029-6033.
  • EIS P, TAM W, SUN L et al.: Accumulation of miR-155 and BIC RNA in human B cell lymphomas. Proc. Natl. Acad. Sci. USA (2005) 102(10):3627-3632.
  • PALATNIK JF, ALLEN E, WU X, SCHOMMER C, SCHWAB R, CARRINGTON JC, WEIGEL D: Control of leaf morphogenesis by microRNAs. Nature (2003) 425(6955):257-263.
  • BRENNECKE J, HIPFNER DR, STARK A, RUSSELL RB, COHEN SM: Bantam encodes a developmentally regulated microRNA that controls cell proliferation and regulates the proapoptotic gene hid in Drosophila. Cell (2003) 113(1):25-36.
  • LIM LP, LAU NC, GARRETT-ENGELE P et al.: Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature (2005) 433(7027):769-773.
  • KRUTZFELDT J, RAJEWSKY N, BRAICH R et al.: Silencing of microRNAs in vivo with ‘antagomirs’. Nature (2005) 438(7068):685-689.
  • HUTVAGNER G, SIMARD MJ, MELLO CC, ZAMORE PD: Sequence-specific inhibition of small RNA function. PLoS Biol. (2004) 2(4):E98.
  • POY MN, ELIASSON L, KRUTZFELDT J et al.: A pancreatic islet-specific microRNA regulates insulin secretion. Nature (2004) 432(7014):226-230.
  • ENRIGHT A, JOHN B, GAUL U et al.: MicroRNA targets in Drosophila. Genome Biol. (2003) 5(1):R1.
  • LEWIS B, SHIH I, JONES-RHOADES M, BARTEL D, BURGE C: Prediction of mammalian microRNA targets. Cell (2003) 115(7):787-798.
  • STARK A, BRENNECKE J, RUSSELL RB, COHEN SM: Identification of Drosophila microRNA targets. PLoS Biol. (2003) 1(3):E60.
  • JOHN B, ENRIGHT AJ, ARAVIN A, TUSCHL T, SANDER C, MARKS DS: Human MicroRNA targets. PLoS Biol. (2004) 2(11):E363.
  • SETHUPATHY P, MEGRAW M, HATZIGEORGIOU AG: A guide through present computational approaches for the identification of mammalian microRNA targets. Nat. Methods (2006) 3(11):881-886.
  • BIRD A: DNA methylation patterns and epigenetic memory. Genes Dev. (2002) 16(1):6-21.
  • JONES PA, WOLFFE AP: Relationships between chromatin organization and DNA methylation in determining gene expression. Semin. Cancer Biol. (1999) 9(5):339-347.
  • ROBERTSON KD, JONES PA: DNA methylation: past, present and future directions. Carcinogenesis (2000) 21(3):461-467.
  • ROUNTREE MR, BACHMAN KE, HERMAN JG, BAYLIN SB: DNA methylation, chromatin inheritance, and cancer. Oncogene (2001) 20(24):3156-3165.
  • BAYLIN SB, ESTELLER M, ROUNTREE MR, BACHMAN KE, SCHUEBEL K, HERMAN JG: Aberrant patterns of DNA methylation, chromatin formation and gene expression in cancer. Hum. Mol. Genet. (2001) 10(7):687-692.
  • McLELLAND M: The frequency and distribution of methylatable DNA sequences in leguminous plant protein coding genes. J. Mol. Evol. (1983) 19(5):346-354.
  • LYKO F, RAMSAHOYE BH, JAENISCH R: DNA methylation in Drosophila melanogaster. Nature (2000) 408(6812):538-540.
  • SELKER EU: Epigenetic phenomena in filamentous fungi: useful paradigms or repeat-induced confusion? Trends Genet. (1997) 13(8):296-301.
  • PERINI G, DIOLAITI D, PORRO A, DELLA VALLE G: In vivo transcriptional regulation of N-Myc target genes is controlled by E-box methylation. Proc. Natl. Acad. Sci. USA (2005) 102(34):12117-12122.
  • YODER JA, SOMAN NS, VERDINE GL, BESTOR TH: DNA (cytosine-5)-methyltransferases in mouse cells and tissues. Studies with a mechanism-based probe. J. Mol. Biol. (1997) 270(3):385-395.
  • MERTINEIT C, YODER JA, TAKEDO T, LAIRD DW, TRASLER JM, BESTOR TH: Sex-specific exons control DNA methyltransferase in mammalian germ cells. Development (1998) 125(5):889-897.
  • BONFILS C, BEAULIEU N, CHAN E, COTTON-MONTPETIT J, MACLEAOD AR: Characterization of the human DNA methyltransferase splice variant Dnmt1b. J. Biol. Chem. (2000) 275(15):10754-10760.
  • OKANO M, XIE S, LI E: Dnmt2 is not required for de novo and maintenance methylation of viral DNA in embryonic stem cells. Nucleic Acids Res. (1998) 26(11):2536-2540.
  • PRADHAN S, BACOLLA A, WELLS RD, ROBERTS RJ: Recombinant human DNA (cytosine-5) methyltransferase. I. Expression, purification, and comparison of de novo and maintenance methylation. J. Biol. Chem. (1999) 274(46):33002-33010.
  • LEI H, OH SP, OKANO M et al.: De novo DNA cytosine methyltransferase activities in mouse embryonic stem cells. Development (1996) 122(10):3195-3205.
  • YODER JA, BESTOR TH: A candidate mammalian DNA methyltransferase related to pmt1p of fission yeast. Hum. Mol. Genet. (1998) 7(2):279-284.
  • AAPOLA U, KAWASAKI K, SCOTT HS et al.: Isolation and initial characterization of a novel zinc finger gene, DNMT3L, on 21q22.3, related to the cytosine-5-methyltransferase 3 gene family. Genomics (2000) 65(3):293-298.
  • BOURC'HIS D, XU GL, LIN CS, BOLLMAN B, BESTOR TH: Dnmt3L and the establishment of maternal genomic imprints. Science (2001) 294(5551):2536-2539.
  • BOURC'HIS D, BESTOR TH: Meiotic catastrophe and retrotransposon reactivation in male germ cells lacking Dnmt3L. Nature (2004) 431(7004):96-99.
  • FENAUX P: Inhibitors of DNA methylation: beyond myelodysplastic syndromes. Nat. Clin. Pract. Oncol. (2005) 2(Suppl. 1):S36-S44.
  • GARBER K: HDAC inhibitors overcome first hurdle. Nat. Biotechnol. (2007) 25(1):17-19.
  • CAMERON EE, BACHMAN KE, MYOHANEN S, HERMAN JG, BAYLIN SB: Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer. Nat. Genet. (1999) 21(1):103-107.
  • KONDO Y, SHEN L, ISSA JP: Critical role of histone methylation in tumor suppressor gene silencing in colorectal cancer. Mol. Cell Biol. (2003) 23(1):206-215.
  • GIUS D, CUI H, BRADBURY CM et al.: Distinct effects on gene expression of chemical and genetic manipulation of the cancer epigenome revealed by a multimodality approach. Cancer Cell (2004) 6(4):361-371.
  • GAN Y, SHEN YH, WANG J et al.: Role of histone deacetylation in cell-specific expression of endothelial nitric-oxide synthase. J. Biol. Chem. (2005) 280(16):16467-16475.
  • MORI T, KIM J, YAMANO T et al.: Epigenetic up-regulation of C-C chemokine receptor 7 and C-X-C chemokine receptor 4 expression in melanoma cells. Cancer Res. (2005) 65(5):1800-1807.
  • ZHANG Y, FATIMA N, DUFAU ML: Coordinated changes in DNA methylation and histone modifications regulate silencing/derepression of luteinizing hormone receptor gene transcription. Mol. Cell Biol. (2005) 25(18):7929-7939.
  • FOLTZ G, RYU GY, YOON JG et al.: Genome-wide analysis of epigenetic silencing identifies BEX1 and BEX2 as candidate tumor suppressor genes in malignant glioma. Cancer Res. (2006) 66(13):6665-6674.
  • VON HOFF DD, SLAVIK M, MUGGIA FM: 5-Azacitidine. A new anticancer drug with effectiveness in acute myelogenous leukemia. Ann. Intern. Med. (1976) 85(2):237-245.
  • SILVERMAN LR, DEMAKOS EP, PETERSON BL et al.: Randomized controlled trial of azacitidine in patients with the myelodysplastic syndrome: a study of the cancer and leukemia group B. J. Clin. Oncol. (2002) 20(10):2429-2440.
  • LEONE G, VOSO MT, TEOFILI L, LUBBERT M: Inhibitors of DNA methylation in the treatment of hematological malignancies and MDS. Clin. Immunol. (2003) 109(1):89-102.
  • SANTINI V, KANTARJIAN HM, ISSA JP: Changes in DNA methylation in neoplasia: pathophysiology and therapeutic implications. Ann. Intern. Med. (2001) 134(7):573-586.
  • FRUHWALD MC, PLASS C: Global and gene-specific methylation patterns in cancer: aspects of tumor biology and clinical potential. Mol. Genet. Metab. (2002) 75(1):1-16.
  • WU J, ISSA JP, HERMAN J, BASSETT DE Jr, NELKIN BD, BAYLIN SB: Expression of an exogenous eukaryotic DNA methyltransferase gene induces transformation of NIH 3T3 cells. Proc. Natl. Acad. Sci. USA (1993) 90(19):8891-8895.
  • YANG SA, DOSHI KD, CHOI KW et al.: DNA methylation changes after 5-aza-2′-deoxycytidine therapy in patients with leukemia. Cancer Res. (2006) 66(10):5495-5503.
  • JONES PA, LAIRD PW: Cancer epigenetics comes of age. Nat. Genet. (1999) 21(2):163-167.
  • CHICOINE E, ESTEVE PO, ROBLEDO O et al.: Evidence for the role of promoter methylation in the regulation of MMP-9 gene expression. Biochem. Biophys. Res. Commun. (2002) 297(4):765-772.
  • SATO N, MAEHARA N, SU GH, GOGGINS M: Effects of 5-aza-2′-deoxycytidine on matrix metalloproteinase expression and pancreatic cancer cell invasiveness. J. Natl. Cancer Inst. (2003) 95(4):327-330.
  • COUILLARD J, DEMERS M, LAVOIE G, ST-PIERRE Y: The role of DNA hypomethylation in the control of stromelysin gene expression. Biochem. Biophys. Res. Commun. (2006) 342(4):1233-2129.
  • FEINBERG AP, VOGELSTEIN B: Hypomethylation of ras oncogenes in primary human cancers. Biochem. Biophys. Res. Commun. (1983) 111(1):47-54.
  • RAO PM, ANTONY A, RAJALAKSHMI S, SARMA DS: Studies on hypomethylation of liver DNA during early stages of chemical carcinogenesis in rat liver. Carcinogenesis (1989) 10(5):933-937.
  • HANADA M, DELIA D, AIELLO A, STADTMAUER E, REED JC: bcl-2 gene hypomethylation and high-level expression in B-cell chronic lymphocytic leukemia. Blood (1993) 82(6):1820-1828.
  • GAUDET F, HODGSON JG, EDEN A et al.: Induction of tumors in mice by genomic hypomethylation. Science (2003) 300(5618):489-492.
  • EDEN A, GAUDET F, WAGHMARE F, JAENISCH R: Chromosomal instability and tumors promoted by DNA hypomethylation. Science (2003) 300(5618):455.
  • MOSER AR, PITOT HC, DOVE WF: A dominant mutation that predisposes to multiple intestinal neoplasia in the mouse. Science (1990) 247(4940):322-324.
  • LUONGO C, MOSER AR, GLEDHILL S, DOVE WF: Loss of Apc+ in intestinal adenomas from Min mice. Cancer Res. (1994) 54(22):5947-5952.
  • LAIRD PW, JACKSON-GRUSBY L, FAZELI A et al.: Suppression of intestinal neoplasia by DNA hypomethylation. Cell (1995) 81(2):197-205.
  • YOOCB, JONES PA: Epigenetic therapy of cancer: past, present and future. Nat. Rev. Drug Discov. (2006) 5(1):37-50.
  • KIMYI, LOGAN JW, MASON JB, ROUBENOFF R: DNA hypomethylation in inflammatory arthritis: reversal with methotrexate. J. Lab. Clin. Med. (1996) 128(2):165-172.
  • NEIDHART M, RETHAGE J, VON KNOCH R et al.: Retrotransposable L1 elements expressed in rheumatoid arthritis synovial tissue: association with genomic DNA hypomethylation and influence on gene expression. Arthritis Rheum. (2000) 43(12):2634-2647.
  • ROACH HI, YAMADA N, CHEUNG KS et al.: Association between the abnormal expression of matrix-degrading enzymes by human osteoarthritic chondrocytes and demethylation of specific CpG sites in the promoter regions. Arthritis Rheum. (2005) 52(10):3110-3124.
  • GARDNER RJ, MACKAY DJ, MUNGALL AJ et al.: An imprinted locus associated with transient neonatal diabetes mellitus. Hum. Mol. Genet. (2000) 9(4):589-596.
  • MACKAY DJ, BOONEN SE, CLAYTON-SMITH J et al.: A maternal hypomethylation syndrome presenting as transient neonatal diabetes mellitus. Hum. Genet. (2006) 120(2):262-269.
  • ABDOLMALEKY HM, CHENG KH, FARAONE SV et al.: Hypomethylation of MB-COMT promoter is a major risk factor for schizophrenia and bipolar disorder. Hum. Mol. Genet. (2006) 15(21):3132-3145.
  • ECKHARDT F, LEWIN J, CORTESE R et al.: DNA methylation profiling of human chromosomes 6, 20 and 22. Nat. Genet. (2006) 38:1378-1385.
  • YAMADA Y, JACKSON-GRUSBY L, LINHART H et al.: Opposing effects of DNA hypomethylation on intestinal and liver carcinogenesis. Proc. Natl. Acad. Sci. USA (2005) 102(38):13580-13585.
  • COUSSENS LM, FINGLETON B, MATRISIAN LM: Matrix metalloproteinase inhibitors and cancer: trials and tribulations. Science (2002) 295(5564):2387-2392.
  • BALBIN M, FUEYO A, TESTER AM et al.: Loss of collagenase-2 confers increased skin tumor susceptibility to male mice. Nat. Genet. (2003) 35(3):252-257.
  • HOUGHTON AM, GRISOLANO JL, BAUMANM ML, KOBAYASHI DK, HAUTAMAKI RD, NEHRING LC: Macrophage elastase (matrix metalloproteinase-12) suppresses growth of lung metastases. Cancer Res. (2006) 66(12):6149-6155.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.